Pigment epithelium‐derived factor is differentially expressed in peripheral neuropathies

Peripheral neuropathies are characterized by asymmetrical slowly progressive weakness with no upper motor neuron signs, and can occur either with or without pain. Due to poor knowledge of the disease mechanisms, available pain treatment is very limited. Because of the difficulties and invasiveness involved when performing direct analysis on peripheral and CNS, pathological markers can be searched for in the cerebrospinal fluid (CSF) as an alternative. To investigate pain mechanisms in peripheral neuropathy and find diagnostic markers, CSF samples were analyzed by a differential expression proteomic approach. We studied CSF from: neuropathic patients with pain (PN), without pain (NPN) and healthy controls (CN). 2‐DE analysis showed ten protein spots differentially expressed, and six of these were identified by MS. In NPN patients we found an expression level decrease of three pigment epithelium‐derived factor (PEDF) protein isoforms. Immunoblot with a specific antibody revealed the presence of additional PEDF isoforms not highlighted by differential expression analysis. Fucose residues on the oligosaccharide chain were found only in the isoforms down regulated in NPN patients. Considered as PEDF has important neurobiological effects, it might be considered an interesting pathology marker.

[1]  T. Taniwaki,et al.  Pigment Epithelium‐Derived Factor Protects Cultured Cerebellar Granule Cells Against Glutamate‐Induced Neurotoxicity , 1997, Journal of neurochemistry.

[2]  B. Chait,et al.  ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. , 2000, Analytical chemistry.

[3]  M. Iadarola,et al.  Cystatin C as a cerebrospinal fluid biomarker for pain in humans , 2003, Pain.

[4]  J. Tombran-Tink,et al.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.

[5]  Jean-Paul Noben,et al.  Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients , 2004, Proteomics.

[6]  J. P. Schwartz,et al.  Survival Effects of Pigment Epithelium-Derived Factor Expressed by a Lentiviral Vector in Rat Cerebellar Granule Cells , 2001, Developmental Neuroscience.

[7]  R. Kuncl,et al.  Pigment epithelium‐derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[8]  V. Notario,et al.  Pigment Epithelium-derived Factor Behaves Like a Noninhibitory Serpin , 1995, The Journal of Biological Chemistry.

[9]  N. Calcutt,et al.  Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats , 2000, Brain Research.

[10]  Michael A. Briggs,et al.  Cloning, expression, and initial characterization of a novel cytokine-like gene family. , 2002, Genomics.

[11]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[12]  In Sik Kim,et al.  Proteomic analysis of differential protein expression in neuropathic pain and electroacupuncture treatment models , 2004, Proteomics.

[13]  J. Eisenach,et al.  Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans , 2004, Pain.

[14]  M. Iadarola,et al.  Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization , 2001, Neuroscience.

[15]  G. Chader,et al.  Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. , 1995, Protein expression and purification.

[16]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[17]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[18]  V. Turk,et al.  Different forms of human cystatin C. , 1990, Biological chemistry Hoppe-Seyler.

[19]  A. Vincent,et al.  Identification of the Neuroprotective Molecular Region of Pigment Epithelium-Derived Factor and Its Binding Sites on Motor Neurons , 2002, The Journal of Neuroscience.

[20]  T. Taniwaki,et al.  Pigment Epithelium‐Derived Factor Is a Survival Factor for Cerebellar Granule Cells in Culture , 1995, Journal of neurochemistry.

[21]  D. Hochstrasser,et al.  Proteomics and its trends facing nature's complexity , 2002, Proteomics.

[22]  E. Alberdi,et al.  Glycosaminoglycans in human retinoblastoma cells: Heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions , 2003, BMC Biochemistry.

[23]  G. Chader,et al.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Enghild,et al.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. , 2003, The Biochemical journal.

[25]  C. Southan,et al.  Proteomic approaches to central nervous system disorders. , 2002, Current opinion in molecular therapeutics.

[26]  J. Sheffield,et al.  Extracellular proteases in developing chick neural retina. , 1991, Experimental eye research.

[27]  D. Hochstrasser,et al.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.

[28]  B. Ghetti,et al.  Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients , 2001, Journal of neuropathology and experimental neurology.

[29]  Oscar Alzate,et al.  Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. , 2004, Brain research. Molecular brain research.

[30]  G. Smith,et al.  A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.

[31]  A. Barrett,et al.  Pyroglutamyl-peptidase I: cloning, sequencing, and characterisation of the recombinant human enzyme. , 2003, Protein expression and purification.

[32]  S. Hashimoto,et al.  Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid , 1997, Spinal Cord.

[33]  H. Takeuchi,et al.  Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases , 2000, Neurology.

[34]  T. Taniwaki,et al.  Pigment epithelium‐derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death , 1998, Journal of neuroscience research.

[35]  A. Sickmann,et al.  Towards a high resolution separation of human cerebrospinal fluid. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  B. Braden,et al.  Three-Dimensional Structure of the Fab from a Human IgM Cold Agglutinin1 , 2000, The Journal of Immunology.

[37]  Jean-Charles Sanchez,et al.  Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob disease , 2004, Proteomics.

[38]  L. Silberstein,et al.  Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment. , 1993, The Journal of clinical investigation.

[39]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[40]  A. Schally,et al.  Cyclic analogues of luteinizing hormone-releasing hormone with significant biological activities. , 1978, Journal of medicinal chemistry.

[41]  A. Bateman,et al.  Post-translational modification of bovine pro-opiomelanocortin. Tyrosine sulfation and pyroglutamate formation, a mass spectrometric study. , 1990, The Journal of biological chemistry.

[42]  C. Barnstable,et al.  PEDF: a multifaceted neurotrophic factor , 2003, Nature Reviews Neuroscience.

[43]  N. Bazan,et al.  Neuroprotection by pigment epithelial‐derived factor against glutamate toxicity in developing primary hippocampal neurons , 1999, Journal of neuroscience research.

[44]  D F Hochstrasser,et al.  Methods for increasing the resolution of two-dimensional protein electrophoresis. , 1988, Analytical biochemistry.

[45]  E. Alberdi,et al.  Binding of Pigment Epithelium-derived Factor (PEDF) to Retinoblastoma Cells and Cerebellar Granule Neurons , 1999, The Journal of Biological Chemistry.

[46]  H. Kourai,et al.  Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. , 2003, Biochemistry.

[47]  T. Jensen,et al.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action , 1999, PAIN®.

[48]  F. Bach.  Beta-endorphin in cerebrospinal fluid: relation to nociception. , 1997, Danish medical bulletin.

[49]  P. Verhaert,et al.  Identification of two‐dimensionally separated human cerebrospinal fluid proteins by N‐terminal sequencing, matrix‐assisted laser desorption/ionization — mass spectrometry, nanoliquid chromatography‐electrospray ionization‐time of flight‐mass spectrometry, and tandem mass spectrometry , 2000, Electrophoresis.

[50]  D. Monard.  Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth , 1988, Trends in Neurosciences.

[51]  K. Blennow,et al.  Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[52]  J. P. Schwartz,et al.  Pigment epithelium‐derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes , 1997, Journal of neuroscience research.

[53]  U. Ungerstedt,et al.  Increased cerebrospinal fluid concentration of aspartate but decreased concentration of nitric oxide breakdown products in women experiencing visceral pain during active labour , 1997, Neuroreport.

[54]  M. Alessio,et al.  Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers. , 2004, Journal of neurotrauma.

[55]  A. Görg,et al.  Improved silver staining protocols for high sensitivity protein identification using matrix‐assisted laser desorption/ionization‐time of flight analysis , 2001, Proteomics.

[56]  D. Lambert,et al.  Identification of nociceptin in human cerebrospinal fluid: comparison of levels in pain and non-pain states , 1998, Pain.

[57]  I. Wilson,et al.  Fucose in N-glycans: from plant to man. , 1999, Biochimica et biophysica acta.

[58]  R. Kuncl,et al.  Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. , 1999, Journal of neuropathology and experimental neurology.